Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Swofford

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Genetics|April 4, 2000
A compound poisson process for relaxing the molecular clockJ P Huelsenbeck, B Larget, D Swofford
Schizophrenia Research|May 1, 1996
Substance use: a powerful predictor of relapse in schizophreniaC D Swofford, J W Kasckow, G Scheller-Gilkey, et al.
The American Journal of Drug and Alcohol Abuse|September 8, 2000
Double jeopardy: schizophrenia and substance useC D Swofford, G Scheller-Gilkey, A H Miller, et al.
The American Journal of Psychiatry|December 1, 1994
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patientsL B Inderbitzin, R R Lewine, G Scheller-Gilkey, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Genetics|April 4, 2000
A compound poisson process for relaxing the molecular clockJ P Huelsenbeck, B Larget, D Swofford
Schizophrenia Research|May 1, 1996
Substance use: a powerful predictor of relapse in schizophreniaC D Swofford, J W Kasckow, G Scheller-Gilkey, et al.
The American Journal of Drug and Alcohol Abuse|September 8, 2000
Double jeopardy: schizophrenia and substance useC D Swofford, G Scheller-Gilkey, A H Miller, et al.
The American Journal of Psychiatry|December 1, 1994
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patientsL B Inderbitzin, R R Lewine, G Scheller-Gilkey, et al.
Pageof 1